Clinical trial
Intravenous (IV) Pantoprazole in Erosive Esophagitis
NCT00133770 · Emory University, Other · Completed
Key facts
| NCT number | NCT00133770 |
|---|---|
| Title | Intravenous (IV) Pantoprazole in Erosive Esophagitis |
| Official title | A Pilot Study of Efficacy and Safety of Continuous Intravenous Infusion of Pantoprazole in the Treatment of Severe Erosive Esophagitis |
| Lead sponsor | Emory University, Other |
| Collaborators | Wyeth is now a wholly owned subsidiary of Pfizer Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Esophagitis |
| Intervention type | Drug |
| Interventions | pantoprazole |
| Enrollment | 20 |
| Start date | Jul 1, 2004 |
| Primary completion | Jul 1, 2006 |
| Completion | Mar 1, 2007 |
| First posted | Aug 24, 2005 |
| Last update posted | Jul 31, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: